$TSNDF
TerrAscend Corp. Stock $tsndf

$tsndf Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000095017023008501 Filed on March 16, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$69.40M	$66.34M	$247.8M
YoY Change	39.75%	-68.47%	17.78%
Cost Of Revenue	$35.50M	$27.33M	$146.3M
YoY Change	2.84%	-72.2%	48.83%
Gross Profit	$33.90M	$39.01M	$101.5M
YoY Change	123.91%	-65.2%	-9.46%
Gross Profit Margin	48.85%	58.8%	40.96%
Selling, General & Admin	$27.73M	$29.67M	$115.6M
YoY Change	22.96%	-63.36%	42.75%
% of Gross Profit	81.8%	76.06%	113.88%
Research & Development		$0.00	$0.00
YoY Change
% of Gross Profit		0.0%	0.0%
Depreciation & Amortization	$3.257M	$3.383M	$10.04M
YoY Change	31.01%	-58.6%	-34.74%
% of Gross Profit	9.61%	8.67%	9.89%
Operating Expenses	$30.09M	$30.66M	$437.4M
YoY Change	19.56%	-65.4%	393.54%
Operating Profit	$3.806M	$8.346M	-$335.9M
YoY Change	-137.95%	-64.45%	-1530.95%
Interest Expense	-$8.106M	$982.0K	$25.73M
YoY Change	364.53%	-97.04%	-22.57%
% of Operating Profit	-212.98%	11.77%
Other Income/Expense, Net	$24.00K	$2.486M	$206.0K
YoY Change	-109.76%	-167.81%	-105.62%
Pretax Income	-$6.514M	$28.25M	-$310.2M
YoY Change	-46.88%	-18.01%	-1000.42%
Income Tax	$12.66M	$14.82M	-$10.78M
% Of Pretax Income		52.46%
Net Earnings	-$22.77M	-$13.56M	-$325.4M
YoY Change	39.2%	-535.74%	-10558.08%
Net Earnings / Revenue	-32.81%	-20.43%	-131.28%
Basic Earnings Per Share	-$0.09		-$1.35
Diluted Earnings Per Share	-$0.09	-$0.05	-$1.35
COMMON SHARES
Basic Shares Outstanding	273.4M	258.6M	244.4M
Diluted Shares Outstanding	267.2M		244.4M

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$34.96M	$29.75M	$29.75M
YoY Change	-62.22%	-62.64%	-62.64%
Cash & Equivalents	$32.93M	$26.16M	$26.16M
Short-Term Investments	$2.026M	$3.595M	$3.595M
Other Short-Term Assets	$19.02M	$23.46M	$23.46M
YoY Change	155.29%	270.3%	270.3%
Inventory	$50.81M	$46.34M	$46.34M
Prepaid Expenses
Receivables	$8.993M	$22.44M	$4.230M
Other Receivables	$1.476M	$18.21M	$18.21M
Total Short-Term Assets	$113.8M	$122.0M	$122.0M
YoY Change	-39.2%	-14.82%	-14.82%
LONG-TERM ASSETS
Property, Plant & Equipment	$214.0M	$215.8M	$245.3M
YoY Change	1.09%	53.32%	44.0%
Goodwill	$95.71M	$90.33M
YoY Change	-59.39%	0.0%
Intangibles	$243.8M	$239.7M
YoY Change	-31.23%	41.85%
Long-Term Investments
YoY Change
Other Assets	$3.594M	$3.462M	$4.299M
YoY Change	-25.48%	-32.26%	-52.65%
Total Long-Term Assets	$587.8M	$579.6M	$579.6M
YoY Change	-30.79%	32.11%	32.11%
TOTAL ASSETS
Total Short-Term Assets	$113.8M	$122.0M	$122.0M
Total Long-Term Assets	$587.8M	$579.6M	$579.6M
Total Assets	$701.6M	$701.6M	$701.6M
YoY Change	-32.31%	20.56%	20.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$50.78M	$44.29M	$44.29M
YoY Change	3.19%	45.97%	45.97%
Accrued Expenses	$2.314M	$521.0K	$521.0K
YoY Change	39.65%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$51.93M	$50.19M	$50.19M
YoY Change	-13.65%	400.42%	400.42%
Total Short-Term Liabilities	$156.1M	$137.9M	$137.9M
YoY Change	5.26%	125.91%	95.99%
LONG-TERM LIABILITIES
Long-Term Debt	$152.8M	$152.6M	$152.6M
YoY Change	-17.37%	-26.32%	-26.32%
Other Long-Term Liabilities	$15.84M	$15.79M	$59.25M
YoY Change	366.05%	20.84%	-3.33%
Total Long-Term Liabilities	$246.2M	$242.5M	$211.8M
YoY Change	-32.16%	-16.93%	-21.07%
TOTAL LIABILITIES
Total Short-Term Liabilities	$156.1M	$137.9M	$137.9M
Total Long-Term Liabilities	$246.2M	$242.5M	$211.8M
Total Liabilities	$402.3M	$380.4M	$382.8M
YoY Change	-21.3%	7.77%	6.82%
SHAREHOLDERS EQUITY
Retained Earnings	-$641.5M	-$618.3M
YoY Change	94.48%	96.49%
Common Stock	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$296.6M	$318.8M	$318.8M
YoY Change
Total Liabilities & Shareholders Equity	$701.6M	$701.6M	$701.6M
YoY Change	-32.31%	20.56%	20.56%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$22.77M	-$13.56M	-$325.4M
YoY Change	39.2%	-535.74%	-10558.08%
Depreciation, Depletion And Amortization	$3.257M	$3.383M	$10.04M
YoY Change	31.01%	-58.6%	-34.74%
Cash From Operating Activities	$8.434M	$7.308M	-$26.12M
YoY Change	-144.75%	-123.12%	-17.89%
INVESTING ACTIVITIES
Capital Expenditures	$2.497M	$15.88M	$39.63M
YoY Change	-40.45%	-257.53%	-201.96%
Acquisitions
YoY Change
Other Investing Activities	-$9.070M	$887.0K	$14.31M
YoY Change	-149.8%	-103.3%	-115.3%
Cash From Investing Activities	-$11.58M	-$15.00M	-$27.58M
YoY Change	-183.24%	-59.39%	-79.17%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net	$1.204M		$42.22M
YoY Change			838.24%
Cash From Financing Activities	9.398M	-1.818M	3.719M
YoY Change	-44.94%	-114.39%	-97.96%
NET CHANGE
Cash From Operating Activities	8.434M	7.308M	-26.12M
Cash From Investing Activities	-11.58M	-15.00M	-27.58M
Cash From Financing Activities	9.398M	-1.818M	3.719M
Net Change In Cash	6.251M	-9.507M	-49.98M
YoY Change	-48.48%	-82.99%	-378.22%
FREE CASH FLOW
Cash From Operating Activities	$8.434M	$7.308M	-$26.12M
Capital Expenditures	$2.497M	$15.88M	$39.63M
Free Cash Flow	$5.937M	-$8.576M	-$65.75M
YoY Change	-125.77%	-60.17%	-1032.02%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2021	us-gaap	Common Stock Shares Authorized Unlimited CommonStockSharesAuthorizedUnlimited	Unlimited
CY2022	us-gaap	Common Stock Shares Authorized Unlimited CommonStockSharesAuthorizedUnlimited	Unlimited
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentNet
CY2022	dei	No Trading Symbol Flag NoTradingSymbolFlag	true
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	00-0000000
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001778129
CY2022Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentNet
CY2021Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	000-56363
CY2022	dei	Entity Registrant Name EntityRegistrantName	TERRASCEND CORP.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	A6
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	3610 Mavis Road
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Mississauga
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	ON
CY2022	dei	Entity Address Country EntityAddressCountry	CA
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	L5C 1W2
CY2022	dei	City Area Code CityAreaCode	855
CY2022	dei	Local Phone Number LocalPhoneNumber	837-7295
CY2022	dei	Security12b Title Security12bTitle	Common Shares
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	false
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	695057079000
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	273403288
CY2022	dei	Auditor Firm AuditorFirmId	1930
CY2022	dei	Auditor Name AuditorName	MNP LLP
CY2022	dei	Auditor Location AuditorLocation	Toronto, Canada
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	26158000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	79642000
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	605000
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	22443000
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	12495000
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	3595000
CY2022Q4	us-gaap	Inventory Net InventoryNet	46335000
CY2021Q4	us-gaap	Inventory Net InventoryNet	36093000
CY2022Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	17349000
CY2021Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	29052000
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4937000
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5029000
CY2022Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	571000
CY2021Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	10178000
CY2022Q4	us-gaap	Assets Current AssetsCurrent	121993000
CY2021Q4	us-gaap	Assets Current AssetsCurrent	172489000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	215812000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	112053000
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	837000
CY2021Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	1977000
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	29451000
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	29561000
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	239704000
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	168425000
CY2022Q4	us-gaap	Goodwill Goodwill	90328000
CY2021Q4	us-gaap	Goodwill Goodwill	90326000
CY2021Q4	trssf	Indemnification Asset Noncurrent IndemnificationAssetNoncurrent	3969000
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3462000
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3135000
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	579594000
CY2021Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	409446000
CY2022Q4	us-gaap	Assets Assets	701587000
CY2021Q4	us-gaap	Assets Assets	581935000
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	44286000
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	27923000
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	2935000
CY2021Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1071000
CY2022Q4	us-gaap	Loans Payable Current LoansPayableCurrent	48335000
CY2021Q4	us-gaap	Loans Payable Current LoansPayableCurrent	8325000
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	5184000
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	9982000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1857000
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1171000
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	521000
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	22000
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	23077000
CY2021Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	9621000
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2599000
CY2022Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	9111000
CY2021Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	8072000
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	137905000
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	66187000
CY2022Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	145852000
CY2021Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	171163000
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	2553000
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	31545000
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	30573000
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	6713000
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	181000
CY2022Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	711000
CY2021Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	54986000
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	30700000
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	14269000
CY2022Q4	trssf	Financing Obligations Noncurrent FinancingObligationsNoncurrent	11198000
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	15792000
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	13069000
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	242511000
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	286794000
CY2022Q4	us-gaap	Liabilities Liabilities	380416000
CY2021Q4	us-gaap	Liabilities Liabilities	352981000
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	259624531
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	190930800
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	0
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	0
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	934972000
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	535418000
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2085000
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2823000
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-618260000
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-314654000
CY2022Q4	us-gaap	Minority Interest MinorityInterest	2374000
CY2021Q4	us-gaap	Minority Interest MinorityInterest	5367000
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	321171000
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	228954000
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	701587000
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	581935000
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	249258000
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	201076000
CY2020	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	139118000
CY2022	us-gaap	Excise And Sales Taxes ExciseAndSalesTaxes	1429000
CY2021	us-gaap	Excise And Sales Taxes ExciseAndSalesTaxes	6866000
CY2020	us-gaap	Excise And Sales Taxes ExciseAndSalesTaxes	6966000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	247829000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	194210000
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	132152000
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	146325000
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	81708000
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	46461000
CY2022	us-gaap	Gross Profit GrossProfit	101504000
CY2021	us-gaap	Gross Profit GrossProfit	112502000
CY2020	us-gaap	Gross Profit GrossProfit	85691000
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	115588000
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	75107000
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	60763000
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	9658000
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	5533000
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3886000
CY2022	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	140727000
CY2021	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	3633000
CY2020	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	343000
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	170357000
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	5007000
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	1089000
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	312000
CY2020	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	6000
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	136000
CY2022	us-gaap	Operating Expenses OperatingExpenses	437419000
CY2021	us-gaap	Operating Expenses OperatingExpenses	89592000
CY2020	us-gaap	Operating Expenses OperatingExpenses	65134000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-335915000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	22910000
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	20557000
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-1061000
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	3584000
CY2020	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	18709000
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	4153000
CY2022	trssf	Gain Loss On Fair Value Of Warrants And Purchase Option Derivative Asset GainLossOnFairValueOfWarrantsAndPurchaseOptionDerivativeAsset	58523000
CY2021	trssf	Gain Loss On Fair Value Of Warrants And Purchase Option Derivative Asset GainLossOnFairValueOfWarrantsAndPurchaseOptionDerivativeAsset	57904000
CY2020	trssf	Gain Loss On Fair Value Of Warrants And Purchase Option Derivative Asset GainLossOnFairValueOfWarrantsAndPurchaseOptionDerivativeAsset	-110518000
CY2022	trssf	Finance And Other Expenses FinanceAndOtherExpenses	35893000
CY2021	trssf	Finance And Other Expenses FinanceAndOtherExpenses	27849000
CY2020	trssf	Finance And Other Expenses FinanceAndOtherExpenses	7427000
CY2022	trssf	Transaction And Restructuring Costs TransactionAndRestructuringCosts	1445000
CY2021	trssf	Transaction And Restructuring Costs TransactionAndRestructuringCosts	3111000
CY2020	trssf	Transaction And Restructuring Costs TransactionAndRestructuringCosts	1129000
CY2021	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	3278000
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-712000
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-4654000
CY2020	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-159000
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	43000
CY2021	us-gaap	Gain Loss On Investments GainLossOnInvestments	6192000
CY2020	us-gaap	Gain Loss On Investments GainLossOnInvestments	533000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-310185000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	44530000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-116852000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-10783000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	28877000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10769000
CY2022	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-299402000
CY2021	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	15653000
CY2020	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-127621000
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-25949000
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-9518000
CY2020	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-14635000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-325351000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	6135000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-142256000
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-738000
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	6485000
CY2020	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-2875000
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-326089000
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	12620000
CY2020	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-145131000
CY2022	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-303959000
CY2021	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	12629000
CY2020	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-139204000
CY2022	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	4557000
CY2021	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	3024000
CY2020	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	-3052000
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-330646000
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	9596000
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-142079000
CY2022	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	4557000
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	3024000
CY2020	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-3052000
CY2022	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-1.24
CY2021	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.07
CY2020	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.93
CY2022	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	-0.11
CY2021	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	-0.05
CY2020	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	-0.10
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.35
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.03
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	244351028
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	181056654
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	149740210
CY2022	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-1.24
CY2021	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.06
CY2020	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.93
CY2022	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	-0.11
CY2021	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	-0.05
CY2020	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	-0.10
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.35
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.03
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	244351028
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	208708664
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	149740210
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	54750000
CY2020	trssf	Stock Issued During Period Value Stock Options Warrants And Restricted Stock Units Exercised StockIssuedDuringPeriodValueStockOptionsWarrantsAndRestrictedStockUnitsExercised	8448000
CY2020	trssf	Shares Issued Value Share Based Payment Arrangement Compensation For Services SharesIssuedValueShareBasedPaymentArrangementCompensationForServices	3750000
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	23977000
CY2020	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	27177000
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10475000
CY2020	trssf	Shares Issued Value Modification Of Warrants Associated With Riv Capital Debt SharesIssuedValueModificationOfWarrantsAssociatedWithRivCapitalDebt	2845000
CY2020	trssf	Noncontrolling Interest Increase Decrease From Capital Contributions NoncontrollingInterestIncreaseDecreaseFromCapitalContributions	393000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-142256000
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-2875000
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-13316000
CY2021	trssf	Stock Issued During Period Value Stock Options Warrants And Restricted Stock Units Exercised StockIssuedDuringPeriodValueStockOptionsWarrantsAndRestrictedStockUnitsExercised	50000000
CY2021	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	34427000
CY2021	trssf	Stock Issued During Period Value Liability Settlement StockIssuedDuringPeriodValueLiabilitySettlement	80000
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	173477000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	14941000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	5656000
CY2021	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	48878000
CY2021	trssf	Noncontrolling Interest Increase Decrease From Capital Contributions NoncontrollingInterestIncreaseDecreaseFromCapitalContributions	-53000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	6135000
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	6485000
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	228954000
CY2022	trssf	Stock Issued During Period Value Stock Options Warrants And Restricted Stock Units Exercised StockIssuedDuringPeriodValueStockOptionsWarrantsAndRestrictedStockUnitsExercised	25927000
CY2022	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	331983000
CY2022	trssf	Stock Issued During Period Value Liability Settlement StockIssuedDuringPeriodValueLiabilitySettlement	264000
CY2022	trssf	Stock Issued During Period Value Debt Settlement Agreement StockIssuedDuringPeriodValueDebtSettlementAgreement	55520000
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	12162000
CY2022	trssf	Noncontrolling Interest Increase Decrease From Capital Contributions NoncontrollingInterestIncreaseDecreaseFromCapitalContributions	-7550000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-325351000
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-738000
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	321171000
CY2022	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-299402000
CY2021	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	15653000
CY2020	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-127621000
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	9082000
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	4941000
CY2022	trssf	Accretion Expenses Net AccretionExpensesNet	-9740000
CY2021	trssf	Accretion Expenses Net AccretionExpensesNet	-4273000
CY2020	trssf	Accretion Expenses Net AccretionExpensesNet	-5232000
CY2022	trssf	Depreciation And Amortization Of Intangible Assets DepreciationAndAmortizationOfIntangibleAssets	22624000
CY2021	trssf	Depreciation And Amortization Of Intangible Assets DepreciationAndAmortizationOfIntangibleAssets	12789000
CY2020	trssf	Depreciation And Amortization Of Intangible Assets DepreciationAndAmortizationOfIntangibleAssets	8337000
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1980000
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1074000
CY2020	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	4184000
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	12162000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	14941000
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	10475000
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-35299000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1245000
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-11970000
CY2022	trssf	Gain Lss On Warrants And Derivative GainLssOnWarrantsAndDerivative	58523000
CY2021	trssf	Gain Lss On Warrants And Derivative GainLssOnWarrantsAndDerivative	57904000
CY2020	trssf	Gain Lss On Warrants And Derivative GainLssOnWarrantsAndDerivative	-110518000
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-1061000
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	3584000
CY2020	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	18709000
CY2022	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	311084000
CY2021	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	8640000
CY2020	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	343000
CY2022	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	1089000
CY2021	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	312000
CY2020	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	6000
CY2022	trssf	Loss On Derecognition Of Right Of Use Assets And Lease Termination LossOnDerecognitionOfRightOfUseAssetsAndLeaseTermination	1163000
CY2021	trssf	Loss On Derecognition Of Right Of Use Assets And Lease Termination LossOnDerecognitionOfRightOfUseAssetsAndLeaseTermination	3278000
CY2022	trssf	Release Of Indemnification Asset ReleaseOfIndemnificationAsset	3973000
CY2021	trssf	Release Of Indemnification Asset ReleaseOfIndemnificationAsset	4504000
CY2021	trssf	Forgiveness Of Loan Principal And Interest ForgivenessOfLoanPrincipalAndInterest	1414000
CY2020	trssf	Fees For Services Related To Nj Licenses FeesForServicesRelatedToNjLicenses	7500000
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	4153000
CY2022	trssf	Bad Debt Expense BadDebtExpense	9941000
CY2022	trssf	Employee Retention Credits Recorded In Other Income EmployeeRetentionCreditsRecordedInOtherIncome	9440000
CY2022	trssf	Debt Modification Fees Expensed DebtModificationFeesExpensed	-2507000
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-712000
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-4654000
CY2020	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-159000
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	43000
CY2021	us-gaap	Gain Loss On Investments GainLossOnInvestments	6192000
CY2020	us-gaap	Gain Loss On Investments GainLossOnInvestments	533000
CY2022	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-2862000
CY2021	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	3209000
CY2020	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	4039000
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-676000
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	18508000
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	8091000
CY2022	trssf	Increase Decrease In Prepaid Expenses And Other Current Assets IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets	-856000
CY2021	trssf	Increase Decrease In Prepaid Expenses And Other Current Assets IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets	1649000
CY2020	trssf	Increase Decrease In Prepaid Expenses And Other Current Assets IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets	5000
CY2022	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-3666000
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-711000
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	726000
CY2020	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	442000
CY2022	trssf	Increase Decrease In Accounts Payable And Accrued Liabilities And Other Payables IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesAndOtherPayables	-12103000
CY2021	trssf	Increase Decrease In Accounts Payable And Accrued Liabilities And Other Payables IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesAndOtherPayables	2820000
CY2020	trssf	Increase Decrease In Accounts Payable And Accrued Liabilities And Other Payables IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesAndOtherPayables	7631000
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1314000
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-663000
CY2020	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-2972000
CY2022	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-9941000
CY2021	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	3750000
CY2022	trssf	Increase Decrease In Contingent Consideration Payable IncreaseDecreaseInContingentConsiderationPayable	-410000
CY2021	trssf	Increase Decrease In Contingent Consideration Payable IncreaseDecreaseInContingentConsiderationPayable	-11394000
CY2020	trssf	Increase Decrease In Contingent Consideration Payable IncreaseDecreaseInContingentConsiderationPayable	-56527000
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	14598000
CY2021	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-6938000
CY2020	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	11358000
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	428000
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	467000
CY2020	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-196000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-21835000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-24162000
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-27944000
CY2022	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-4288000
CY2021	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-7653000
CY2020	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-9027000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-26123000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-31815000
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-36971000
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	39631000
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	39835000
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	43784000
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	2261000
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	376000
CY2020	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	842000
CY2022	us-gaap	Proceeds From Collection Of Lease Receivables ProceedsFromCollectionOfLeaseReceivables	515000
CY2021	us-gaap	Proceeds From Collection Of Lease Receivables ProceedsFromCollectionOfLeaseReceivables	677000
CY2020	us-gaap	Proceeds From Collection Of Lease Receivables ProceedsFromCollectionOfLeaseReceivables	118000
CY2021	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	469000
CY2020	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	153000
CY2021	us-gaap	Payments To Acquire Limited Partnership Interests PaymentsToAcquireLimitedPartnershipInterests	50000000
CY2022	trssf	Deposits For Business Acquisition DepositsForBusinessAcquisition	1065000
CY2020	trssf	Deposits For Business Acquisition DepositsForBusinessAcquisition	1389000
CY2022	trssf	Payments Made For Land Contracts PaymentsMadeForLandContracts	1271000
CY2022	trssf	Cash Portion Of Consideration Paid In Acquisitions Net Of Cash Acquired CashPortionOfConsiderationPaidInAcquisitionsNetOfCashAcquired	-16227000
CY2021	trssf	Cash Portion Of Consideration Paid In Acquisitions Net Of Cash Acquired CashPortionOfConsiderationPaidInAcquisitionsNetOfCashAcquired	42736000
CY2020	trssf	Cash Portion Of Consideration Paid In Acquisitions Net Of Cash Acquired CashPortionOfConsiderationPaidInAcquisitionsNetOfCashAcquired	-739000
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-27486000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-131801000
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-45005000
CY2022	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	-93000
CY2021	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	-620000
CY2020	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	-885000
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-27579000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-132421000
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-45890000
CY2022	trssf	Proceeds From Options And Warrants Exercised ProceedsFromOptionsAndWarrantsExercised	24342000
CY2021	trssf	Proceeds From Options And Warrants Exercised ProceedsFromOptionsAndWarrantsExercised	30785000
CY2020	trssf	Proceeds From Options And Warrants Exercised ProceedsFromOptionsAndWarrantsExercised	7287000
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	42221000
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	4500000
CY2020	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	48893000
CY2022	trssf	Loan Modification Fees Paid LoanModificationFeesPaid	4977000
CY2020	trssf	Loan Modification Fees Paid LoanModificationFeesPaid	2250000
CY2022	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	43419000
CY2021	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	766000
CY2020	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	196348000
CY2022	us-gaap	Payments Of Distributions To Affiliates PaymentsOfDistributionsToAffiliates	1539000
CY2022	trssf	Payments Of Capital Distribution To Noncontrolling Interest PaymentsOfCapitalDistributionToNoncontrollingInterest	7550000
CY2021	trssf	Payments Of Capital Distribution To Noncontrolling Interest PaymentsOfCapitalDistributionToNoncontrollingInterest	53000
CY2020	trssf	Payments Of Capital Distribution To Noncontrolling Interest PaymentsOfCapitalDistributionToNoncontrollingInterest	-393000
CY2022	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	6630000
CY2021	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	18274000
CY2020	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	90657000
CY2022	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	1125000
CY2021	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	173477000
CY2020	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	71023000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	3719000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	182201000
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	133251000
CY2020	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	155000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3719000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	182201000
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	133406000
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-49983000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	17965000
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	50545000
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-2896000
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2451000
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-481000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	79642000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	59226000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	9162000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	26763000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	79642000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	59226000
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	9917000
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	37060000
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	11204000
CY2022	us-gaap	Interest Paid Net InterestPaidNet	26840000
CY2021	us-gaap	Interest Paid Net InterestPaidNet	21171000
CY2020	us-gaap	Interest Paid Net InterestPaidNet	1955000
CY2022	trssf	Payments For Lease Termination Fee PaymentsForLeaseTerminationFee	3300000
CY2022	trssf	Stock Issued During Period Value Canopy Usa Arrangement StockIssuedDuringPeriodValueCanopyUsaArrangement	55520000
CY2022	trssf	Business Combination Consideration Transferred Equity Issued And Liabilities Incurred BusinessCombinationConsiderationTransferredEquityIssuedAndLiabilitiesIncurred	338739000
CY2021	trssf	Business Combination Consideration Transferred Equity Issued And Liabilities Incurred BusinessCombinationConsiderationTransferredEquityIssuedAndLiabilitiesIncurred	34427000
CY2020	trssf	Noncash Or Part Noncash Acquisition Notes Receivable Settled NoncashOrPartNoncashAcquisitionNotesReceivableSettled	3032000
CY2022	trssf	Noncash Or Part Noncash Acquisition Promissory Notes Issued NoncashOrPartNoncashAcquisitionPromissoryNotesIssued	10000000
CY2021	trssf	Noncash Or Part Noncash Acquisition Promissory Notes Issued NoncashOrPartNoncashAcquisitionPromissoryNotesIssued	8839000
CY2022	trssf	Stock Issued During Period Value Liability Settlement StockIssuedDuringPeriodValueLiabilitySettlement	264000
CY2020	us-gaap	Stock Issued1 StockIssued1	3750000
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2187000
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	450000
CY2020	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	4544000
CY2022	us-gaap	Nature Of Operations NatureOfOperations	<div style="text-indent:0.0%;display:flex;margin-top:10.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">1.</span><div id="notes_fs" style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Nature of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">operations</span></div></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">TerrAscend Corp. (“TerrAscend” or the “Company”) was incorporated under the Ontario Business Corporations Act on </span><span style="font-size:10.0pt;font-family:"Times New Roman", serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">March 7, 2017</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">. TerrAscend provides cannabis products, brands, and services to the United States (“U.S.”) and Canadian cannabinoid markets where cannabis production or consumption has been legalized for therapeutic or adult use. TerrAscend operates a number of synergistic businesses, including Gage Growth ("Gage"), a cultivator, processor and retailer in Michigan; KISA Enterprises MI, LLC and KISA Holdings LLC (collectively "Pinnacle"); The Apothecarium (“The Apothecarium”), a cannabis dispensary with several retail locations in California, Pennsylvania and New Jersey; TerrAscend NJ, LLC ("TerrAscend NJ"), a cultivator, processor and retailer with operations in New Jersey; Ilera Healthcare (“Ilera”), Pennsylvania’s medical cannabis cultivator, processor and dispenser; HMS Health, LLC and HMS Processing, LLC (collectively “HMS”), a medical cannabis cultivator and processor based in Maryland; Valhalla Confections, a manufacturer of cannabis-infused edibles; State Flower, a California-based cannabis producer operating a licensed cultivation facility in San Francisco; and Arise Bioscience Inc., a manufacturer and distributor of hemp-derived products. Notwithstanding various states in the U.S. which have implemented medical marijuana laws, or which have otherwise legalized the use of cannabis, the use of cannabis remains illegal under U.S. federal law for any purpose, by way of the Controlled Substances Act of 1970.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">The Company has been listed on the Canadian Securities Exchange ("CSE") since May 3, 2017, having the ticker symbol "TER" and effective October 22, 2018, the Company began trading on OTCQX under the ticker symbol "TRSSF". The Company’s registered office is located at 3610 Mavis Road, Mississauga, Ontario, L5C 1W2.</span></p>
CY2022	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2017-03-07
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-618260000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	26158000
CY2022	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-299402000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-26123000
CY2022Q4	trssf	Trade Receivables Gross TradeReceivablesGross	14786000
CY2021Q4	trssf	Trade Receivables Gross TradeReceivablesGross	12134000
CY2022Q4	trssf	Number Of Lessee Finance Lease NumberOfLesseeFinanceLease	3
CY2021Q4	trssf	Number Of Lessee Finance Lease NumberOfLesseeFinanceLease	1
CY2022	trssf	Lessee Finance Lease Option To Extend And Terminate LesseeFinanceLeaseOptionToExtendAndTerminate	Certain leases include one or more options to renew or terminate the lease at the Company’s discretion. The Company regularly evaluates lease renewal and termination options and, when they are reasonably certain of exercise, includes the renewal or termination option in the lease term.
CY2022	us-gaap	Lessee Finance Lease Existence Of Option To Extend LesseeFinanceLeaseExistenceOfOptionToExtend	true
CY2022	us-gaap	Lessee Finance Lease Existence Of Option To Terminate LesseeFinanceLeaseExistenceOfOptionToTerminate	true
CY2022Q4	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	277000
CY2021Q4	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	326000
CY2022Q4	us-gaap	Other Receivables Gross Current OtherReceivablesGrossCurrent	17936000
CY2021Q4	us-gaap	Other Receivables Gross Current OtherReceivablesGrossCurrent	370000
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2022	us-gaap	Number Of Reporting Units NumberOfReportingUnits	7
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	10556000
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	335000
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	22443000
CY2022Q4	us-gaap	Preferred Stock Convertible Conversion Ratio PreferredStockConvertibleConversionRatio	0.001
CY2022	us-gaap	Derivatives Embedded Derivatives DerivativesEmbeddedDerivatives	<p style="text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">(v) Embedded derivative liabilities</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">The Company evaluates its financial instruments to determine if those instruments or any embedded components of those instruments qualify as derivatives that need to be separately accounted for in accordance with ASC 815 </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;font-style:italic;min-width:fit-content;">Derivatives and Hedging</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Embedded derivatives satisfying certain criteria are recorded at fair value at issuance and marked-to-market at each</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">balance </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">sheet date with the change in the fair value recorded as income or expense. In addition, upon the occurrence of an event that requires the derivative liability to be reclassified to equity, the derivative liability is revalued to fair value at that date.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p>
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	27652010
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">(y) Use of significant estimates and judgments</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">The preparation of the Company’s consolidated financial statements requires management to make judgments, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities, income and expenses. The estimates and associated assumptions are based on historical experience and various other factors that are believed to be reasonable under the circumstances, the results of which form the basis of making the judgments about carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates. Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimates are revised and in any future periods affected.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Management has applied significant estimates and judgements related to the following:</span></p><div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:10.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">i)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;font-style:italic;min-width:fit-content;">Inventory</span></div></div><p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">The net realizable value of inventory represents the estimated selling price in the ordinary course of business less the reasonably predictable costs of completion, disposal and transportation. The Company estimates the net realizable value of inventories, taking into account the most reliable evidence available at each reporting date. The determination of net realizable value requires significant judgment, including consideration of factors such as shrinkage, the aging of and future demand for inventory, expected future selling price the Company expects to realize by selling the inventory, and the contractual arrangements with customers. Reserves for excess and obsolete inventory are based upon quantities on hand, projected volumes from demand forecasts and net realizable value. The future realization of these inventories may be affected by market-driven changes that may reduce future selling prices. A change to these assumptions could impact the Company’s inventory valuation and gross profit.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p><p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">The impact of inventory reserves is reflected in cost of sales.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p><div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:10.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">ii)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;font-style:italic;min-width:fit-content;">Revenue recognition</span></div></div><p style="margin-left:9.2%;text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">From time to time, the Company partakes in sales agreements with suppliers in which it also purchases inventory. As part of the five-step revenue model, the Company assesses whether instances of bulk sales made to suppliers of goods have commercial substance and should be recognized as revenue, or whether they should be assessed under ASC 845 </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;font-style:italic;min-width:fit-content;">Nonmonetary Transactions</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">, which requires management judgment to determine if the transaction has commercial substance</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;font-style:italic;min-width:fit-content;">.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;font-style:italic;min-width:fit-content;"> </span></p><div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:10.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">iii)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;font-style:italic;min-width:fit-content;">Share based payments</span></div></div><p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">In calculating share-based compensation expense, key estimates are used such as, the rate of forfeiture of options granted, the expected life of the option, the volatility of the Company’s stock price, and the risk-free interest rate.</span></p><div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:10.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">iv)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;font-style:italic;min-width:fit-content;">Warrant Liability</span></div></div><p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">In calculating the fair value of warrants issued, the Company includes key estimates such as the volatility of the Company’s stock price and the risk-free interest rate. The Company uses judgment to select methods used and in performing the fair value calculations at the initial measurement at issuance, as well as for subsequent measurement on a recurring basis.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p><div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:10.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">v)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;font-style:italic;min-width:fit-content;">Income taxes</span></div></div><p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">The extent to which deferred tax assets can be recognized is based on an assessment of the probability of the Company generating future taxable income against which the deferred tax assets can be utilized. In addition, significant judgment is required in classifying transactions and assessing probable outcomes of tax positions taken, and in assessing the impact of any legal or economic limits or uncertainties in various tax jurisdictions.</span></p><p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Provisions for taxes are made using the best estimate of the amount expected to be paid based on a qualitative assessment of all relevant factors. The Company reviews the adequacy of these provisions at the end of the reporting period. It is possible, however, that at some future date, an additional liability could result from audits by taxing authorities. If the final outcome of these tax-related matters is different from the amounts that were initially recorded, such differences will affect the tax provisions in the period in which such determination is made.</span></p><div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:10.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">vi)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;font-style:italic;min-width:fit-content;">Impairment of goodwill and intangible assets </span></div></div><p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Goodwill and indefinite lived intangible assets are reviewed for impairment annually and whenever there are events or changes in circumstances that indicate the carrying amount has been impaired. Definite lived intangible assets are tested for impairment when there are indications that an asset may be impaired. If it is determined that it is more likely than not that the fair value of a reporting unit are less than its carrying value, additional quantitative impairment testing is performed which compares the carrying value of the reporting unit to its estimated fair value.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p><p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">The Company uses an income-based approach as necessary to assess the fair values of intangible assets and its reporting units for goodwill testing purposes. Under the income approach, fair value is based on the present value of estimated cash flows. An impaired asset is written down to its estimated fair value based on the most recent information available.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p><p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Fair value is determined as the amount that would be obtained from the sale of the asset in an arm’s length transaction between knowledgeable and willing parties. Determining the value in use requires the Company to estimate expected future cash flows associated with the assets and a suitable discount rate in order to calculate present value. A number of factors, including historical results, business plans, forecasts, and market data are used to determine the fair value of the reporting unit and intangible assets.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p><div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:10.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">vii)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;font-style:italic;min-width:fit-content;">Impairment of long-lived assets</span></div></div><p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">The Company evaluates the recoverability of long-lived assets, including property and equipment, ROU assets, and definite lived intangible assets, whether events or changes in circumstances indicate that the carrying value of the asset, or asset group, may not be recoverable.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p><p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">When the Company determines that the carrying value of the long-lived asset may not be recoverable based upon the existence of one or more of the indicators, the assets are assessed for impairment based on the estimate of future undiscounted cash flows expected to result from the use of the asset and its eventual disposition. If the carrying value of an asset exceeds its estimated future undiscounted cash flows, an impairment loss is recorded for the excess of the asset’s carrying value over its fair value.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p><div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:10.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">viii)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;font-style:italic;min-width:fit-content;">Business combinations </span></div></div><p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Classification of an acquisition as a business combination or an asset acquisition depends on whether the asset acquired constitutes a business, which can be a complex judgement. The Company has determined that its acquisitions in Note 4 are business combinations under ASC 805 </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;font-style:italic;min-width:fit-content;">Business Combinations</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p><p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">In a business combination, substantially all identifiable assets, liabilities and contingent liabilities acquired are recorded at the date of acquisition at their respective fair values. One of the most significant areas of judgment and estimation relates to the determination of the fair value of these assets and liabilities, including the fair value of contingent consideration, if applicable. If any intangible assets are identified, depending on the type of intangible asset and the complexity of determining its fair value, the Company may utilize an independent external valuation expert to develop the fair value, using appropriate valuation techniques, which are generally based on a forecast of the total expected future net cash flows. These valuations are linked closely to the assumptions made by management regarding the future performance of the assets concerned and any changes in the discount rate applied. The Company elected to measure each NCI at its fair value as of the acquisition date based on an appraisal of the real estate acquired using the market approach, specifically the direct comparison approach of comparable properties.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p><div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:10.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">ix)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;font-style:italic;min-width:fit-content;">Contingent Consideration</span></div></div><p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Contingent consideration payable as the result of a business combination is recorded at the date of acquisition at fair value. The fair value of contingent consideration is subject to significant judgement and estimates, such as projected future revenue. Subsequent changes to the fair value of contingent consideration are measured at each reporting date, with changes recognized through profit or loss.</span></p><div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:10.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">x)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;font-style:italic;min-width:fit-content;">Incremental borrowing rates</span></div></div><p style="margin-left:9.173%;text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Lease payments are discounted using the rate implicit in the lease if that rate is readily available. If that rate cannot be easily determined, the lessee is required to use its incremental borrowing rate. The incremental borrowing rate is the rate of interest that the Company estimates it would have to pay on a collateralized basis to borrow an amount equal to the lease payments under similar terms. The Company calculates its incremental borrowing rate as the interest rate the Company would pay to borrow funds necessary to obtain an asset of similar value over similar terms taking into consideration the economic factors and the credit risk rating at the commencement date of the lease.</span></p><p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">In addition, the Company utilizes a discount rate to determine the appropriate fair value of convertible debentures and loans issued with warrants attached. The discount rate applied reflects the interest rate that the Company would have to pay to borrow a similar amount at a similar term and with a similar security.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p><div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:10.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">xi)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;font-style:italic;min-width:fit-content;">Control, joint control or level of influence</span></div></div><p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">When determining the appropriate basis of accounting for the Company’s interests in affiliates, the Company makes judgments about the degree of influence that it exerts directly or through an arrangement over the investees’ relevant activities.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p><div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:10.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">xii)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;font-style:italic;min-width:fit-content;">ERC</span></div></div><p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">The Coronavirus Aid, Relief and Economic Securities Act ("CARES Act") provides for an employee retention credit ("ERC") which is a refundable tax credit for businesses that continued to pay employees while shut down due to the COVID-19 pandemic, or had significant declines in gross receipts from March 13, 2020 to December 31, 2021. Eligible employers can claim the ERC on an original or adjusted employment tax return for a period within those dates. The Company has elected to account for the credit as a government grant. There is limited grant accounting guidance within U.S. GAAP that is applicable to for-profit entities, therefore, the Company has elected to follow the grant accounting model in International Accounting Standard ("IAS") 20, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;font-style:italic;min-width:fit-content;">Accounting for Government Grants and Disclosure of Government Assistance. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Accordingly, the Company recognizes government grants for which there is a reasonable assurance of compliance with grant conditions and receipt of credits and has therefore recognized a receivable for the total credit amount on the consolidated balance sheets as of December 31, 2022 (refer to Note 3). The determination of the collectability of the ERC requires significant judgement, including assessment of the Company's eligibility based on the facts and circumstances. While the Company believes that collection of the ERC is probable, there is some uncertainty around collection due to the nature of the Company's industry.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p>
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	12495000
CY2022	us-gaap	Payments To Employees PaymentsToEmployees	14903000
CY2022	trssf	Employee Retention Credits Recorded In Other Income EmployeeRetentionCreditsRecordedInOtherIncome	9440000
CY2022	trssf	Acquisition Of Gage Related To Erc AcquisitionOfGageRelatedToErc	5463000
CY2022Q4	trssf	Trade Receivables Gross TradeReceivablesGross	14786000
CY2021Q4	trssf	Trade Receivables Gross TradeReceivablesGross	12134000
CY2022Q4	trssf	Provisions For Sales Returns And Expected Credit Losses ProvisionsForSalesReturnsAndExpectedCreditLosses	10556000
CY2021Q4	trssf	Provisions For Sales Returns And Expected Credit Losses ProvisionsForSalesReturnsAndExpectedCreditLosses	335000
CY2022Q4	trssf	Trade Receivables Net TradeReceivablesNet	4230000
CY2021Q4	trssf	Trade Receivables Net TradeReceivablesNet	11799000
CY2022Q4	trssf	Trade Receivable Current TradeReceivableCurrent	4045000
CY2021Q4	trssf	Trade Receivable Current TradeReceivableCurrent	10913000
CY2022Q4	trssf	Trade Receivable3190 Days TradeReceivable3190Days	614000
CY2021Q4	trssf	Trade Receivable3190 Days TradeReceivable3190Days	569000
CY2022Q4	trssf	Trade Receivable Over90 Days TradeReceivableOver90Days	10127000
CY2021Q4	trssf	Trade Receivable Over90 Days TradeReceivableOver90Days	652000
CY2022Q4	trssf	Provisions For Sales Returns And Expected Credit Losses ProvisionsForSalesReturnsAndExpectedCreditLosses	10556000
CY2021Q4	trssf	Provisions For Sales Returns And Expected Credit Losses ProvisionsForSalesReturnsAndExpectedCreditLosses	335000
CY2022Q4	trssf	Trade Receivables Net TradeReceivablesNet	4230000
CY2021Q4	trssf	Trade Receivables Net TradeReceivablesNet	11799000
CY2022Q4	trssf	Number Of Customers Agreed To Payment Plan Over Ninety Days NumberOfCustomersAgreedToPaymentPlanOverNinetyDays	1
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	9941000
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	335000
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1782000
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	324000
CY2021	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	968000
CY2022	trssf	Expected Credit Losses ExpectedCreditLosses	10556000
CY2021	trssf	Expected Credit Losses ExpectedCreditLosses	357000
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	659000
CY2021	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	2772000
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	10556000
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	335000
CY2020Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	37556000
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	1063000
CY2021	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	29668000
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	3584000
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	12535000
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	750000
CY2022	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	7040000
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-1061000
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	5184000
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	5184000
CY2022	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	7040000
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	1181000
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	269000
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	15280000
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	6760000
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	26406000
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	26777000
CY2022Q4	trssf	Inventory Accessories Supplies And Consumables InventoryAccessoriesSuppliesAndConsumables	3468000
CY2021Q4	trssf	Inventory Accessories Supplies And Consumables InventoryAccessoriesSuppliesAndConsumables	2287000
CY2022Q4	us-gaap	Inventory Net InventoryNet	46335000
CY2021Q4	us-gaap	Inventory Net InventoryNet	36093000
CY2022Q4	trssf	Facility Held For Sale FacilityHeldForSale	67300
CY2021Q4	trssf	Remaining Net Book Value Of Asset RemainingNetBookValueOfAsset	343000
CY2020	trssf	Written Down Of Net Book Value Of Lighting And Irrigation Assets WrittenDownOfNetBookValueOfLightingAndIrrigationAssets	0
CY2020	trssf	Specific Impairment Of Asset Recognized SpecificImpairmentOfAssetRecognized	823000
CY2020	trssf	Impairment Of Intellectual Property ImpairmentOfIntellectualProperty	423000
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	235496000
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	122115000
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	19684000
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	10062000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	215812000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	112053000
CY2022	trssf	Property And Equipment Capitalized Borrowing Costs PropertyAndEquipmentCapitalizedBorrowingCosts	0
CY2021	trssf	Property And Equipment Capitalized Borrowing Costs PropertyAndEquipmentCapitalizedBorrowingCosts	0
CY2022	us-gaap	Depreciation Depreciation	10043000
CY2021	us-gaap	Depreciation Depreciation	6137000
CY2020	us-gaap	Depreciation Depreciation	2930000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	181522000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	24575000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	156947000
CY2022Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	82757000
CY2022Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	82757000
CY2022Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	264279000
CY2022Q4	trssf	Intangible Assets Excluding Goodwill Accumulated Amortization IntangibleAssetsExcludingGoodwillAccumulatedAmortization	24575000
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	239704000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	155742000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	12090000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	143652000
CY2021Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	24773000
CY2021Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	24773000
CY2021Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	180515000
CY2021Q4	trssf	Intangible Assets Excluding Goodwill Accumulated Amortization IntangibleAssetsExcludingGoodwillAccumulatedAmortization	12090000
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	168425000
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	12581000
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6652000
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5407000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	7745000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	7548000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	7282000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	7267000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	7185000
CY2022Q4	us-gaap	Loans Payable LoansPayable	194187000
CY2022Q4	us-gaap	Loans Payable Current LoansPayableCurrent	48335000
CY2022Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	145852000
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	26840000
CY2021	us-gaap	Interest Expense Debt InterestExpenseDebt	21171000
CY2020	us-gaap	Interest Expense Debt InterestExpenseDebt	1955000
CY2022Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	35000000
CY2022Q4	us-gaap	Interest Expense Debt InterestExpenseDebt	5000000
CY2020Q4	us-gaap	Goodwill Goodwill	72796000
CY2021	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	22537000
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	5007000
CY2021Q4	us-gaap	Goodwill Goodwill	90326000
CY2022	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	170359000
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	170357000
CY2022Q4	us-gaap	Goodwill Goodwill	90328000
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	121527000
CY2021	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	2233000
CY2020	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	343000
CY2022	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	19200000
CY2021	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	1400000
CY2022	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	140727000
CY2021	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	3633000
CY2020	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	343000
CY2022	trssf	Impairment Of Cultivation And Processing Licenses ImpairmentOfCultivationAndProcessingLicenses	79462000
CY2022	trssf	Impairment Of Retail Licenses ImpairmentOfRetailLicenses	42065000
CY2021	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	3633000
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	170357000
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	5007000
CY2020Q4	us-gaap	Loans Payable LoansPayable	171341000
CY2021	trssf	Loan Principal Net Of Transaction Costs LoanPrincipalNetOfTransactionCosts	9605000
CY2021	us-gaap	Interest Expense Long Term Debt Increase Decrease InterestExpenseLongTermDebtIncreaseDecrease	25479000
CY2021	us-gaap	Debt Instrument Periodic Payment DebtInstrumentPeriodicPayment	25717000
CY2021	trssf	Forgiveness Of Loan Principal And Interest ForgivenessOfLoanPrincipalAndInterest	1414000
CY2021	trssf	Effects Of Movements In Foreign Exchange EffectsOfMovementsInForeignExchange	194000
CY2021Q4	us-gaap	Loans Payable LoansPayable	179488000
CY2022	trssf	Loan Principal Net Of Transaction Costs LoanPrincipalNetOfTransactionCosts	43419000
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Long Term Debt BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt	70605000
CY2022	trssf	Loan Amendment Fee LoanAmendmentFee	2470000
CY2022	us-gaap	Interest Expense Long Term Debt Increase Decrease InterestExpenseLongTermDebtIncreaseDecrease	35231000
CY2022	us-gaap	Debt Instrument Periodic Payment DebtInstrumentPeriodicPayment	69067000
CY2022	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount	59449000
CY2022	trssf	Effects Of Movements In Foreign Exchange EffectsOfMovementsInForeignExchange	-3570000
CY2022Q4	trssf	Percentage Of Prepayment Price PercentageOfPrepaymentPrice	1.0322
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	48876000
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	105610000
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	758000
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	2274000
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	42446000
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	199964000
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	29451000
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	29561000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1857000
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1171000
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	31545000
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	30573000
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	33402000
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	31744000
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	6673000
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	168000
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	521000
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	22000
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	6713000
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	181000
CY2022Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	7234000
CY2021Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	203000
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	5028000
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	3986000
CY2020	us-gaap	Operating Lease Expense OperatingLeaseExpense	3066000
CY2021	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	3278000
CY2021Q4	trssf	Area Of The Lease Facility Terminated AreaOfTheLeaseFacilityTerminated	22000
CY2022	trssf	Operating Lease Liability Borrowing Rate OperatingLeaseLiabilityBorrowingRate	0.10
CY2022	trssf	Right Of Use Assets Borrowing Rate RightOfUseAssetsBorrowingRate	0.10
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	4613000
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	956000
CY2022Q4	trssf	Operating And Finance Lease Liability Payments Due Year Five OperatingAndFinanceLeaseLiabilityPaymentsDueYearFive	5569000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	39742000
CY2022Q4	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	3868000
CY2022Q4	trssf	Operating And Finance Lease Liability Payments Due After Year Five OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFive	43610000
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P12Y9M18D
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P14Y2M12D
CY2022Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P6Y9M18D
CY2021Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P5Y6M
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1069
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1072
CY2022Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0989
CY2021Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.1000
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	5053000
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	3987000
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3097000
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	9773000
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	220000
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	40000
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	6913000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	5400000
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	739000
CY2022Q4	trssf	Operating And Finance Lease Liability Payments Due Next Twelve Months OperatingAndFinanceLeaseLiabilityPaymentsDueNextTwelveMonths	6139000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	5403000
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	2757000
CY2022Q4	trssf	Operating And Finance Lease Liability Payments Due Year Two OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo	8160000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	5387000
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	908000
CY2022Q4	trssf	Operating And Finance Lease Liability Payments Due Year Three OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree	6295000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	5111000
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	928000
CY2022Q4	trssf	Operating And Finance Lease Liability Payments Due Year Four OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour	6039000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	65656000
CY2022Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	10156000
CY2022Q4	trssf	Operating And Finance Lease Liability Payments Due OperatingAndFinanceLeaseLiabilityPaymentsDue	75812000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	32255000
CY2022Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	2922000
CY2022Q4	trssf	Operating And Finance Lease Liability Undiscounted Excess Amount OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount	35177000
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	33402000
CY2022Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	7234000
CY2022Q4	trssf	Operating And Finance Lease Liability OperatingAndFinanceLeaseLiability	40635000
CY2022Q4	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	431000
CY2022Q4	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	433000
CY2022Q4	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	447000
CY2022Q4	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	262000
CY2022Q4	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	1573000
CY2022Q4	trssf	Financing Obligations Due In Next Twelve Months FinancingObligationsDueInNextTwelveMonths	1915000
CY2022Q4	trssf	Financing Obligations Due In Second Year FinancingObligationsDueInSecondYear	1940000
CY2022Q4	trssf	Financing Obligations Due In Third Year FinancingObligationsDueInThirdYear	1986000
CY2022Q4	trssf	Financing Obligations Due In Fourth Year FinancingObligationsDueInFourthYear	2032000
CY2022Q4	trssf	Financing Obligations Due In Fifth Year FinancingObligationsDueInFifthYear	2079000
CY2022Q4	trssf	Financing Obligations Due After Fifth Year FinancingObligationsDueAfterFifthYear	5680000
CY2022Q4	trssf	Financing Obligations Due FinancingObligationsDue	15632000
CY2022Q4	trssf	Financing Obligations Undiscounted Excess Amount FinancingObligationsUndiscountedExcessAmount	3630000
CY2022Q4	trssf	Financing Obligations FinancingObligations	12002000
CY2022Q4	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	1000
CY2022	us-gaap	Common Stock Voting Rights CommonStockVotingRights	Holders of Common Shares are entitled to receive notice of, and to attend, all meetings of the shareholders of the Company and shall have one vote per each Common Share
CY2022	trssf	Number Of Vote Per Each Common Share Held NumberOfVotePerEachCommonShareHeld	1
CY2022	trssf	Proportionate Voting Share ProportionateVotingShare	0.001
CY2021Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	1643000
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	12162000
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	14942000
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10475000
CY2020Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1625701
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	10493015
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y14D
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.26
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1877000
CY2019Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	3.30
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	12861050
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.82
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1816496
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.46
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	4174221
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	4.19
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	17363348
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y11M15D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.49
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	112675000
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	2.58
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	3905000
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	10.11
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1376496
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	3.97
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	6838347
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	4.46
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	198986
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	5.95
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	12854519
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y10M2D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.85
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	27557000
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	4.22
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	7058840
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.69
CY2022	trssf	Share Based Compensation Arrangement By Share Based Payment Award Replacement Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardReplacementOptionsGrantsInPeriod	4940364
CY2022	trssf	Share Based Compensation Arrangements By Share Based Payment Award Replacement Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardReplacementOptionsGrantsInPeriodWeightedAverageExercisePrice	2.99
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	778245
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.62
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	3397022
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	5.96
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	567211
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	7.14
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	20111246
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y10M9D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.63
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	320000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	12447071
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y9M18D
CY2022Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	3.23
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	320000
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	7664172
CY2022	trssf	Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedWeightedAverageRemainingContractualTerm	P8Y2M15D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	4.28
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1355000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	6667000
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	10123000
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.7755
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.7789
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.7905
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.8151
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.8229
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.8709
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0163
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0351
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0090
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0172
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0035
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0160
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0000
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0000
CY2022	trssf	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeitures Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeituresRate	0.2611
CY2020	trssf	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeitures Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeituresRate	0.2321
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	280099
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	157788
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	122311
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	33733000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	174408
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	40665
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	63883
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	192171
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	13294000
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	1176397
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	669478
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	283450
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	415640
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	13050000
CY2021Q4	us-gaap	Minority Interest MinorityInterest	5367000
CY2020Q4	us-gaap	Minority Interest MinorityInterest	3802000
CY2022	trssf	Minority Interest Capital And Distributions Contributions MinorityInterestCapitalAndDistributionsContributions	-7550000
CY2021	trssf	Minority Interest Capital And Distributions Contributions MinorityInterestCapitalAndDistributionsContributions	-53000
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	4557000
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	3024000
CY2022Q4	us-gaap	Minority Interest MinorityInterest	2374000
CY2021Q4	us-gaap	Minority Interest MinorityInterest	5367000
CY2022Q4	us-gaap	Notes Payable Related Parties Current And Noncurrent NotesPayableRelatedPartiesCurrentAndNoncurrent	250000
CY2021Q4	us-gaap	Notes Payable Related Parties Current And Noncurrent NotesPayableRelatedPartiesCurrentAndNoncurrent	3550000
CY2022	trssf	Income Loss From Continuing And Discontinued Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingAndDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-310185000
CY2021	trssf	Income Loss From Continuing And Discontinued Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingAndDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	44530000
CY2022	trssf	Income Loss From Continuing And Discontinued Operations Before Income Taxes Domestic IncomeLossFromContinuingAndDiscontinuedOperationsBeforeIncomeTaxesDomestic	-337019000
CY2021	trssf	Income Loss From Continuing And Discontinued Operations Before Income Taxes Domestic IncomeLossFromContinuingAndDiscontinuedOperationsBeforeIncomeTaxesDomestic	15513000
CY2020	trssf	Income Loss From Continuing And Discontinued Operations Before Income Taxes Domestic IncomeLossFromContinuingAndDiscontinuedOperationsBeforeIncomeTaxesDomestic	10270000
CY2022	trssf	Income Loss From Continuing And Discontinued Operations Before Income Taxes Foreign IncomeLossFromContinuingAndDiscontinuedOperationsBeforeIncomeTaxesForeign	26834000
CY2021	trssf	Income Loss From Continuing And Discontinued Operations Before Income Taxes Foreign IncomeLossFromContinuingAndDiscontinuedOperationsBeforeIncomeTaxesForeign	29017000
CY2020	trssf	Income Loss From Continuing And Discontinued Operations Before Income Taxes Foreign IncomeLossFromContinuingAndDiscontinuedOperationsBeforeIncomeTaxesForeign	-127122000
CY2022	trssf	Income Loss From Continuing And Discontinued Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingAndDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-310185000
CY2021	trssf	Income Loss From Continuing And Discontinued Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingAndDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	44530000
CY2020	trssf	Income Loss From Continuing And Discontinued Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingAndDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-116852000
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	21692000
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	21522000
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	15262000
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2718000
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	8600000
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	7476000
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	106000
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	1000
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	24516000
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	30122000
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	22739000
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-29297000
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-1353000
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-4210000
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-6002000
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	108000
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-623000
CY2020	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-7137000
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-35299000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1245000
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-11970000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-10783000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	28877000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10769000
CY2020	trssf	Income Loss From Continuing And Discontinued Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingAndDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-116852000
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-65139000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	9351000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-24539000
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	28607000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.092
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	17858000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.401
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	9809000
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.084
CY2022	trssf	Income Tax Reconciliation Return To Provision True Up IncomeTaxReconciliationReturnToProvisionTrueUp	-7359000
CY2022	trssf	Effective Income Tax Rate Reconciliation Return To Provision True Up EffectiveIncomeTaxRateReconciliationReturnToProvisionTrueUp	0.024
CY2021	trssf	Effective Income Tax Rate Reconciliation Return To Provision True Up EffectiveIncomeTaxRateReconciliationReturnToProvisionTrueUp	0.000
CY2020	trssf	Effective Income Tax Rate Reconciliation Return To Provision True Up EffectiveIncomeTaxRateReconciliationReturnToProvisionTrueUp	0.000
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	35775000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	-0.115
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	0.000
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	0.000
CY2022	trssf	Income Tax Reconciliation Changes In Unrecognized Tax Benefits IncomeTaxReconciliationChangesInUnrecognizedTaxBenefits	10662000
CY2022	trssf	Effective Income Tax Rate Reconciliation Changes In Unrecognized Tax Benefits EffectiveIncomeTaxRateReconciliationChangesInUnrecognizedTaxBenefits	-0.035
CY2021	trssf	Income Tax Reconciliation Changes In Unrecognized Tax Benefits IncomeTaxReconciliationChangesInUnrecognizedTaxBenefits	-4274000
CY2021	trssf	Effective Income Tax Rate Reconciliation Changes In Unrecognized Tax Benefits EffectiveIncomeTaxRateReconciliationChangesInUnrecognizedTaxBenefits	-0.096
CY2020	trssf	Income Tax Reconciliation Changes In Unrecognized Tax Benefits IncomeTaxReconciliationChangesInUnrecognizedTaxBenefits	-2821000
CY2020	trssf	Effective Income Tax Rate Reconciliation Changes In Unrecognized Tax Benefits EffectiveIncomeTaxRateReconciliationChangesInUnrecognizedTaxBenefits	0.024
CY2022	trssf	Income Tax Reconciliation Extinguishment Of Debt IncomeTaxReconciliationExtinguishmentOfDebt	-8239000
CY2022	trssf	Effective Income Tax Rate Reconciliation Extinguishment Of Debt EffectiveIncomeTaxRateReconciliationExtinguishmentOfDebt	0.027
CY2021	trssf	Effective Income Tax Rate Reconciliation Extinguishment Of Debt EffectiveIncomeTaxRateReconciliationExtinguishmentOfDebt	0.000
CY2020	trssf	Effective Income Tax Rate Reconciliation Extinguishment Of Debt EffectiveIncomeTaxRateReconciliationExtinguishmentOfDebt	0.000
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	2554000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.008
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	3138000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.070
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	2028000
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.017
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	19146000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.062
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	5992000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.252
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-6290000
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.054
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-7067000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.023
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	9849000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.135
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	5193000
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.044
CY2022	trssf	Effective Income Tax Rate Reconciliation Revaluation Of Equity Or Warrants EffectiveIncomeTaxRateReconciliationRevaluationOfEquityOrWarrants	-12290000
CY2022	trssf	Effective Income Tax Rate Reconciliation Revaluation Of Equity Or Warrant EffectiveIncomeTaxRateReconciliationRevaluationOfEquityOrWarrant	0.039
CY2021	trssf	Effective Income Tax Rate Reconciliation Revaluation Of Equity Or Warrants EffectiveIncomeTaxRateReconciliationRevaluationOfEquityOrWarrants	-13479000
CY2021	trssf	Effective Income Tax Rate Reconciliation Revaluation Of Equity Or Warrant EffectiveIncomeTaxRateReconciliationRevaluationOfEquityOrWarrant	-0.303
CY2020	trssf	Effective Income Tax Rate Reconciliation Revaluation Of Equity Or Warrants EffectiveIncomeTaxRateReconciliationRevaluationOfEquityOrWarrants	23227000
CY2020	trssf	Effective Income Tax Rate Reconciliation Revaluation Of Equity Or Warrant EffectiveIncomeTaxRateReconciliationRevaluationOfEquityOrWarrant	-0.199
CY2022	trssf	Effective Income Tax Rate Reconciliation Revaluation Of Contingent Consideration EffectiveIncomeTaxRateReconciliationRevaluationOfContingentConsideration	-223000
CY2022	trssf	Effective Income Tax Rate Reconciliation Revaluation Of Contingent Consideration Percent EffectiveIncomeTaxRateReconciliationRevaluationOfContingentConsiderationPercent	0.001
CY2021	trssf	Effective Income Tax Rate Reconciliation Revaluation Of Contingent Consideration EffectiveIncomeTaxRateReconciliationRevaluationOfContingentConsideration	753000
CY2021	trssf	Effective Income Tax Rate Reconciliation Revaluation Of Contingent Consideration Percent EffectiveIncomeTaxRateReconciliationRevaluationOfContingentConsiderationPercent	0.017
CY2020	trssf	Effective Income Tax Rate Reconciliation Revaluation Of Contingent Consideration EffectiveIncomeTaxRateReconciliationRevaluationOfContingentConsideration	3929000
CY2020	trssf	Effective Income Tax Rate Reconciliation Revaluation Of Contingent Consideration Percent EffectiveIncomeTaxRateReconciliationRevaluationOfContingentConsiderationPercent	-0.034
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-4699000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.015
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	425000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.010
CY2020	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	698000
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.006
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-10783000
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.035
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	28877000
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.648
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10769000
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.092
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	9318000
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	12008000
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	2872000
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	4884000
CY2022	trssf	Unrecognized Tax Benefits Increases Decrease Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesDecreaseResultingFromPriorPeriodTaxPositions	8655000
CY2021	trssf	Unrecognized Tax Benefits Increases Decrease Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesDecreaseResultingFromPriorPeriodTaxPositions	-4546000
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	1962000
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	3028000
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	18883000
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	9318000
CY2022Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	2170000
CY2021Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	1071000
CY2022Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	13223000
CY2021Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	9318000
CY2022Q4	trssf	Unrecognized Tax Benefits That If Recognized Would Result In Adjustments To Other Accounts UnrecognizedTaxBenefitsThatIfRecognizedWouldResultInAdjustmentsToOtherAccounts	6758000
CY2021Q4	trssf	Unrecognized Tax Benefits That If Recognized Would Result In Adjustments To Other Accounts UnrecognizedTaxBenefitsThatIfRecognizedWouldResultInAdjustmentsToOtherAccounts	0
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	42022000
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	26321000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	2837000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	700000
CY2022Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	4689000
CY2021Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	2038000
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	3768000
CY2021Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	4101000
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	8700000
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1696000
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	62016000
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	34856000
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	61274000
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	24097000
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	742000
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	10759000
CY2021Q4	trssf	Deferred Tax Liabilities Convertible Debentures DeferredTaxLiabilitiesConvertibleDebentures	10065000
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	31442000
CY2021Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	14963000
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	31442000
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	25028000
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	30700000
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	14269000
CY2022Q4	us-gaap	Fdic Indemnification Asset FDICIndemnificationAsset	3973000
CY2022Q4	us-gaap	Decrease In Unrecognized Tax Benefits Is Reasonably Possible DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible	2100000
CY2022	trssf	Office And General Expense OfficeAndGeneralExpense	26000000
CY2021	trssf	Office And General Expense OfficeAndGeneralExpense	10091000
CY2020	trssf	Office And General Expense OfficeAndGeneralExpense	10810000
CY2022	us-gaap	Professional Fees ProfessionalFees	12942000
CY2021	us-gaap	Professional Fees ProfessionalFees	12041000
CY2020	us-gaap	Professional Fees ProfessionalFees	13613000
CY2022	trssf	Operating And Finance Lease Expense OperatingAndFinanceLeaseExpense	5302000
CY2021	trssf	Operating And Finance Lease Expense OperatingAndFinanceLeaseExpense	4523000
CY2020	trssf	Operating And Finance Lease Expense OperatingAndFinanceLeaseExpense	3721000
CY2022	trssf	Facility And Maintenance Expense FacilityAndMaintenanceExpense	4050000
CY2021	trssf	Facility And Maintenance Expense FacilityAndMaintenanceExpense	1396000
CY2020	trssf	Facility And Maintenance Expense FacilityAndMaintenanceExpense	2079000
CY2022	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	44814000
CY2021	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	30256000
CY2020	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	18792000
CY2022	trssf	Share Based Compensation Expense ShareBasedCompensationExpense	12162000
CY2021	trssf	Share Based Compensation Expense ShareBasedCompensationExpense	14942000
CY2020	trssf	Share Based Compensation Expense ShareBasedCompensationExpense	10075000
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	10318000
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1858000
CY2020	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1673000
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	115588000
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	75107000
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	60763000
CY2020	trssf	Fees For Services Related To Nj Licenses FeesForServicesRelatedToNjLicenses	7500000
CY2020	trssf	Fees For Services Related To Nj Licenses First Payment FeesForServicesRelatedToNjLicensesFirstPayment	3750000
CY2020Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1625701
CY2020	trssf	Fees For Services Related To Nj Licenses Second Payment FeesForServicesRelatedToNjLicensesSecondPayment	3750000
CY2020	trssf	Aggregate Fees For Services Related To Nj Licenses AggregateFeesForServicesRelatedToNjLicenses	15000000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	247829000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	194210000
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	132152000
CY2022	trssf	Number Of Major Customers NumberOfMajorCustomers	0
CY2021	trssf	Number Of Major Customers NumberOfMajorCustomers	0
CY2020	trssf	Number Of Major Customers NumberOfMajorCustomers	0
CY2022	trssf	Sales Returns SalesReturns	1040000
CY2022	trssf	Loan Interest Accretion LoanInterestAccretion	39059000
CY2021	trssf	Loan Interest Accretion LoanInterestAccretion	24989000
CY2020	trssf	Loan Interest Accretion LoanInterestAccretion	7034000
CY2022	trssf	Indemnification Asset Release IndemnificationAssetRelease	3973000
CY2021	trssf	Indemnification Asset Release IndemnificationAssetRelease	4504000
CY2021	trssf	Forgiveness Of Loan Principal And Interest ForgivenessOfLoanPrincipalAndInterest	1414000
CY2022	trssf	Employee Retention Credits EmployeeRetentionCredits	9440000
CY2022	trssf	Debt Modification Fees DebtModificationFees	2507000
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	206000
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	230000
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-393000
CY2022	trssf	Finance And Other Expenses FinanceAndOtherExpenses	35893000
CY2021	trssf	Finance And Other Expenses FinanceAndOtherExpenses	27849000
CY2020	trssf	Finance And Other Expenses FinanceAndOtherExpenses	7427000
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	247829000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	194210000
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	132152000
CY2022Q4	us-gaap	Noncurrent Assets NoncurrentAssets	579594000
CY2021Q4	us-gaap	Noncurrent Assets NoncurrentAssets	409446000
CY2022	trssf	Fair Value Assets Transfer Between Levels Amount FairValueAssetsTransferBetweenLevelsAmount	0
CY2021	trssf	Fair Value Assets Transfer Between Levels Amount FairValueAssetsTransferBetweenLevelsAmount	0
CY2021Q3	trssf	Derivative Asset Outstanding Term DerivativeAssetOutstandingTerm	P1Y8M12D
CY2021Q3	trssf	Derivative Asset Risk Free Rate DerivativeAssetRiskFreeRate	0.003
CY2021Q3	trssf	Derivative Asset Earnings Before Interest Taxes Depreciation And Amortization Discount Rate DerivativeAssetEarningsBeforeInterestTaxesDepreciationAndAmortizationDiscountRate	0.150
CY2021Q3	trssf	Derivative Asset Earnings Before Interest Taxes Depreciation And Amortization Volatility DerivativeAssetEarningsBeforeInterestTaxesDepreciationAndAmortizationVolatility	0.600
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-1061000
CY2021	trssf	Discount Rate Utilized To Determine Present Value Of Liabilities DiscountRateUtilizedToDeterminePresentValueOfLiabilities	0.122
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	3584000
CY2020	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	18709000
CY2022	trssf	Foreign Currency Fluctuating Percentage ForeignCurrencyFluctuatingPercentage	0.10
CY2020Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	132257000
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	58158000
CY2021	trssf	Exercise Of Warrants ExerciseOfWarrants	-19113000
CY2021Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	54986000
CY2022	trssf	Warrants Addition On Acquisition WarrantsAdditionOnAcquisition	6756000
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	59341000
CY2022	trssf	Exercise Of Warrants ExerciseOfWarrants	-1690000
CY2022Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	711000
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	59341000
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	58158000
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-110518000
CY2021	trssf	Initial Measurement Of Purchase Option Derivative Asset InitialMeasurementOfPurchaseOptionDerivativeAsset	1122000
CY2021	trssf	Revaluation Of Purchase Option Derivative Asset RevaluationOfPurchaseOptionDerivativeAsset	254000
CY2021Q4	us-gaap	Derivative Assets DerivativeAssets	868000
CY2022	trssf	Revaluation Of Purchase Option Derivative Asset RevaluationOfPurchaseOptionDerivativeAsset	818000
CY2022Q4	us-gaap	Derivative Assets DerivativeAssets	50000
CY2022	trssf	Revaluation Of Purchase Option Derivative Asset RevaluationOfPurchaseOptionDerivativeAsset	818000
CY2021	trssf	Revaluation Of Purchase Option Derivative Asset RevaluationOfPurchaseOptionDerivativeAsset	254000
CY2022Q4	trssf	Derivative Asset Outstanding Term DerivativeAssetOutstandingTerm	P0Y6M
CY2021Q4	trssf	Derivative Asset Outstanding Term DerivativeAssetOutstandingTerm	P1Y3M18D
CY2022Q4	trssf	Derivative Asset Risk Free Rate DerivativeAssetRiskFreeRate	0.025
CY2021Q4	trssf	Derivative Asset Risk Free Rate DerivativeAssetRiskFreeRate	0.004
CY2022Q4	trssf	Derivative Asset Earnings Before Interest Taxes Depreciation And Amortization Discount Rate DerivativeAssetEarningsBeforeInterestTaxesDepreciationAndAmortizationDiscountRate	0.155
CY2021Q4	trssf	Derivative Asset Earnings Before Interest Taxes Depreciation And Amortization Discount Rate DerivativeAssetEarningsBeforeInterestTaxesDepreciationAndAmortizationDiscountRate	0.150
CY2022Q4	trssf	Derivative Asset Earnings Before Interest Taxes Depreciation And Amortization Volatility DerivativeAssetEarningsBeforeInterestTaxesDepreciationAndAmortizationVolatility	0.371
CY2021Q4	trssf	Derivative Asset Earnings Before Interest Taxes Depreciation And Amortization Volatility DerivativeAssetEarningsBeforeInterestTaxesDepreciationAndAmortizationVolatility	0.440
CY2022	us-gaap	Unrealized Gain Loss On Foreign Currency Derivatives Net Before Tax UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax	2389000
CY2022Q4	trssf	Factoring Interests FactoringInterests	14903000

Files In Submission

Name	View Source	Status
0000950170-23-008501-index-headers.html	Edgar Link	pending
0000950170-23-008501-index.html	Edgar Link	pending
0000950170-23-008501.txt	Edgar Link	pending
0000950170-23-008501-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
img150748066_0.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R115.htm	Edgar Link	pending
R116.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
trssf-20221231.htm	Edgar Link	pending
trssf-20221231.xsd	Edgar Link	pending
trssf-ex10_10.htm	Edgar Link	pending
trssf-ex10_11.htm	Edgar Link	pending
trssf-ex10_12.htm	Edgar Link	pending
trssf-ex10_4.htm	Edgar Link	pending
trssf-ex10_5.htm	Edgar Link	pending
trssf-ex10_6.htm	Edgar Link	pending
trssf-ex10_9.htm	Edgar Link	pending
trssf-ex21_1.htm	Edgar Link	pending
trssf-ex23_1.htm	Edgar Link	pending
trssf-ex31_1.htm	Edgar Link	pending
trssf-ex31_2.htm	Edgar Link	pending
trssf-ex32_1.htm	Edgar Link	pending
trssf-ex4_1.htm	Edgar Link	pending
trssf-ex4_2.htm	Edgar Link	pending
trssf-ex4_3.htm	Edgar Link	pending
trssf-ex4_4.htm	Edgar Link	pending
trssf-ex4_5.htm	Edgar Link	pending
trssf-ex4_6.htm	Edgar Link	pending
trssf-ex4_7.htm	Edgar Link	pending
trssf-20221231_cal.xml	Edgar Link	unprocessable
trssf-20221231_def.xml	Edgar Link	unprocessable
trssf-20221231_lab.xml	Edgar Link	unprocessable
trssf-20221231_pre.xml	Edgar Link	unprocessable
trssf-20221231_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TSNDF
TerrAscend Corp. Stock $tsndf

2023 Q1 Form 10-K Financial Statement

#000095017023008501 Filed on March 16, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TSNDF TerrAscend Corp. Stock $tsndf

2023 Q1 Form 10-K Financial Statement

#000095017023008501 Filed on March 16, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TSNDF
TerrAscend Corp. Stock $tsndf